Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study.

BMJ Open
Anna PlymMats Lambe

Abstract

To compare the loss of working time due to sick leave by treatment strategy for localised prostate cancer. Nationwide cohort study. Sweden. A total of 15 902 working-aged men with localised low or intermediate-risk prostate cancer diagnosed during 2007-2016 from the Prostate Cancer Data Base Sweden, together with 63 464 prostate cancer-free men. Men were followed until 2016. Using multistate Markov models, we calculated the proportion of men on work, sick leave, disability pension and death, together with the amount of time spent in each state. All-cause and cause-specific estimates were calculated. During the first 5 years after diagnosis, men with active surveillance as their primary treatment strategy spent a mean of 17 days (95% CI 15 to 19) on prostate cancer-specific sick leave, as compared with 46 days (95% CI 44 to 48) after radical prostatectomy and 44 days (95% CI 38 to 50) after radiotherapy. The pattern was similar after adjustment for cancer and sociodemographic characteristics. There were no differences between the treatment strategies in terms of days spent on sick leave due to depression, anxiety or stress. Five years after diagnosis, over 90% of men in all treatment strategies were free from sick leave, disabil...Continue Reading

References

Apr 9, 2009·Scandinavian Journal of Urology and Nephrology·Lena HohwüOve Gustafsson
Jun 22, 2010·Journal of the National Cancer Institute·Pär StattinUNKNOWN National Prostate Cancer Register (NPCR) of Sweden
May 27, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anna Bill-AxelsonGunnar Steineck
May 9, 2012·International Journal of Epidemiology·Mieke Van HemelrijckUNKNOWN NPCR and PCBaSe Sweden
Jul 6, 2014·European Urology·Stacy LoebPär Stattin
Jul 19, 2014·Acta Oncologica·Katarina TomicPär Stattin
Aug 28, 2014·European Urology·Paul R WombleUNKNOWN Michigan Urological Surgery Improvement Collaborative
Sep 14, 2014·Journal of Cancer Survivorship : Research and Practice·Sigrun DahlSophie Dorothea Fosså
May 12, 2015·BJU International·Sigrid CarlssonPer Fransson
Jul 8, 2015·JAMA : the Journal of the American Medical Association·Matthew R Cooperberg, Peter R Carroll
Jan 13, 2016·Scandinavian Journal of Urology·Joen SveistrupPeter M Petersen
Feb 18, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald C ChenSuneil Jain
Sep 15, 2016·The New England Journal of Medicine·J L DonovanUNKNOWN ProtecT Study Group*
Oct 22, 2016·JAMA Oncology·Stacy LoebPär Stattin
Mar 23, 2017·JAMA : the Journal of the American Medical Association·Daniel A BarocasDavid F Penson
Nov 22, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A PetterssonP Stattin
Jan 18, 2018·Prostate Cancer and Prostatic Diseases·Raisa S PompePierre I Karakiewicz

❮ Previous
Next ❯

Software Mentioned

R
STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.